Atherotech Diagnostics Lab Release: VAP® Lipid Panel Demonstrates Value Of Cholesterol Subfraction Measurement In Heart Disease Treatment And Risk Assessment
Published: Nov 19, 2013
DALLAS--(BUSINESS WIRE)--Researchers using the Atherotech VAP® Lipid Panel demonstrated the comprehensive lipid profile’s value in heart disease treatment and risk assessment. Through measurement of HDL cholesterol subfractions and remnant lipoproteins, the VAP Lipid Panel was able to identify specific lipid disorders for personalized treatment that may lead to improved outcomes in two scientific abstracts presented today at the American Heart Association (AHA) Scientific Sessions 2013 in Dallas.
Help employers find you! Check out all the jobs and post your resume.